Text Size

Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity

Sato T., Wada K., Arahori H., Kuno N., Imoto K., Iwahashi-Shima C., Kusaka S.


  • 2012
  • American Journal of Ophthalmology
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Applied Visual Science, Osaka University Graduate School of Medicine, Suita, Japan; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan; Research and Development Center, Santen Pharmaceutical Co, Ltd, Nara, Japan; Department of Ophthalmology, Sakai Hospital, Kinki University Faculty of Medicine, 2-7-1 Harayamadai, Minami-ku, Sakai, 590-0132 Osaka, Japan

Related Publications

Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.


Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

Yamamoto Y.; Taniguchi T.; Shimazaki A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022